Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Basel Medical Group Ltd O...

    NASDAQ: BMGL · Real-Time Price · USD
    1.65
    -0.09 (-5.17%)
    At close: Jul 03, 2025, 3:52 PM
    1.78
    7.83%
    After-hours: Jul 03, 2025, 04:57 PM EDT

    Basel Medical Ltd Ordinary Shares Statistics

    Share Statistics

    Basel Medical Ltd Ordinary Shares has 18.79M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 18.79M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 15,824

    FTD / Avg. Volume

    n/a
    		 0.28%

    Short Selling Information

    The latest short interest is 436.78K, so 2.33% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 436.78K

    Short % of Shares Out

    n/a
    		 2.33%

    Short % of Float

    n/a
    		 5.09%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Basel Medical Ltd Ordinary Shares.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.57.

    Current Ratio

    n/a
    		 2.26

    Quick Ratio

    n/a
    		 2.25

    Debt / Equity

    n/a
    		 0.57

    Debt / EBITDA

    n/a
    		 1.38

    Debt / FCF

    n/a
    		 1.71

    Interest Coverage

    n/a
    		 12.46

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $314,091.34

    Profits Per Employee

    n/a
    		 $64,775

    Employee Count

    n/a
    		 32

    Asset Turnover

    n/a
    		 0.62

    Inventory Turnover

    n/a
    		 31.21

    Taxes

    Income Tax

    n/a
    		 331.76K

    Effective Tax Rate

    n/a
    		 13.8%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0, so Basel Medical Ltd Ordinary Shares's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 3.23

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 39.05

    Average Volume (20 Days)

    n/a
    		 5,716,545

    Income Statement

    In the last 12 months, Basel Medical Ltd Ordinary Shares had revenue of 10.05M and earned 2.07M in profits. Earnings per share was 0.

    Revenue

    n/a
    		 10.05M

    Gross Profit

    n/a
    		 7.8M

    Operating Income

    n/a
    		 2.2M

    Net Income

    n/a
    		 2.07M

    EBITDA

    n/a
    		 3.11M

    EBIT

    n/a
    		 2.58M

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 1.95M in cash and 4.29M in debt, giving a net cash position of -2.34M.

    Cash & Cash Equivalents

    n/a
    		 1.95M

    Total Debt

    n/a
    		 4.29M

    Net Cash

    n/a
    		 -2.34M

    Retained Earnings

    n/a
    		 7.56M

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 2.51M and capital expenditures -7.92K, giving a free cash flow of 2.5M.

    Operating Cash Flow

    n/a
    		 2.51M

    Capital Expenditures

    n/a
    		 -7.92K

    Free Cash Flow

    n/a
    		 2.5M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross margin is 77.63%, with operating and profit margins of 21.84% and 20.62%.

    Gross Margin

    n/a
    		 77.63%

    Operating Margin

    n/a
    		 21.84%

    Pretax Margin

    n/a
    		 23.92%

    Profit Margin

    n/a
    		 20.62%

    EBITDA Margin

    n/a
    		 30.94%

    EBIT Margin

    n/a
    		 21.84%

    FCF Margin

    n/a
    		 24.89%

    Dividends & Yields

    BMGL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BMGL.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist